| Date Filed | Type | Description |
| 08/08/2019 |
T-3/A
| Form T-3/A - Application for qualification of trust indentures: [Amend] |
| 07/19/2019 |
T-3
| Form T-3 - Application for qualification of trust indentures: |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 02/08/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/31/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/12/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/09/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 12/09/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 12/01/2016 |
SC 13D/A
| Broadfin Capital, LLC reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
SC 13D/A
| Sarissa Capital Management LP reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 |
8-K
| Quarterly results |
| 11/29/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/15/2016 |
SC 13G
| Aegerion Pharmaceuticals, Inc. reports a 5.6% stake in Aegerion Pharmaceuticals, Inc. |
| 11/07/2016 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 11/04/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
| 11/03/2016 |
8-K
| Form 8-K - Current report |
| 10/24/2016 |
8-K
| Form 8-K - Current report |
| 10/24/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/20/2016 |
8-K
| Other Events |
| 10/20/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/06/2016 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 10/03/2016 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/12/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 08/10/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 08/09/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 08/09/2016 |
8-K
| Quarterly results |
|